The ELZA team were well represented at the CXL Experts’ Meeting 2023, held last weekend at the Mövenpick Hotel, Zurich Airport.
Prof. Farhad Hafezi, Dr. Emilio Torres-Netto and Léonard Kollros were all involved in giving presentations and courses at this conference that contains the world’s leading figures in corneal cross-linking.
Discover how Dr. Emilio A. Torres-Netto, a rising star in ophthalmology, earned the prestigious 2023 Waring Memorial Award
Sunday, September 10th, 2023, continued the trend of informative presentations at the ESCRS 2023 conference in Vienna. Here’s a straightforward rundown of the day’s events:
During the Croatian Organisation of Cataract and Refractive Surgery (CROCS) 2023 annual meeting held in Zadar, Croatia, on 12th and 13th October, Prof. Farhad Hafezi lectured on “CXL in 2023” and he and ELZA’s CEO, Nikki Hafezi, performed Croatia’s largest keratoconus in Down Syndrome screening event to date.
ELZA Specialist Dr Dion Paridaens Elected President of the European Society of Ophthalmic Plastic & Reconstructive Surgery (ESOPRS) in Naples On September 16, 2023, Dr.
Total corneal wavefront analysis, facilitated by the MS39 system, represents a significant advancement in therapeutic excimer laser refractive surgery.
The pandemic’s onset saw a significant shift from traditional learning methods to online platforms. As the article notes, “The COVID-19 pandemic catapulted the world’s population into Zoom meetings, virtual congresses, live webinars…
Prof. Farhad Hafezi joins NYU Grossman as a Research Professor in Ophthalmology. An in-depth look at his career and contributions. #HafeziNYU #Ophthalmology
The VSY Biotechnology Ophthalmology Star Awards (OSA) for 2023 were announced at the Satellite Symposium during the ESCRS conference in Vienna. The awards recognize contributions to the field of ophthalmology, specifically research and clinical studies that have advanced understanding and treatment of eye diseases. This year, Dr. Nan-ji Lu from the ELZA Institute in Zurich received the third-place award for her clinical study titled “A New Keratoconus Staging System Based on OCT.” Dr. Lu’s research focuses on a new system for staging keratoconus, a condition affecting the cornea, and has implications for its diagnosis and treatment.
On August 12, 2023, at Humo Arena, Tashkent, 63 Down syndrome children were screened for keratoconus under Nikki Hafezi’s leadership. Discover the importance of early detection
